ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,550Medicare Part D Prescriptions Filled, Including Refills

Rank: 122 out of 973

$528K Total Retail Price of All Prescriptions

Rank: 124 out of 973

459 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 459 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 459 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 9,680 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 498 449 1 2
SIMVASTATIN 412 386 2 1
HYDROCHLOROTHIAZIDE 376 361 3 11
AMLODIPINE BESYLATE 347 340 4 7
WARFARIN SODIUM 331 302 5 10
LISINOPRIL 309 281 6 3
HYDROCODONE-ACETAMINOPHEN 279 248 S3 7 4
OMEPRAZOLE 272 240 8 5
POTASSIUM CHLORIDE 262 252 9 9
METOPROLOL SUCCINATE 222 190 10 17
ATENOLOL 219 212 11 16
DONEPEZIL HCL 184 184 12 26
FUROSEMIDE 180 167 13 6
SERTRALINE HCL 177 174 14 21
CITALOPRAM HBR 169 146 15 14
LANTUS 164 140 16 39
FLUTICASONE PROPIONATE 130 125 17 35
ALENDRONATE SODIUM 128 128 18 24
GABAPENTIN 127 122 19 12
PRAVASTATIN SODIUM 126 118 20 22
LOVASTATIN 121 118 21 38
METFORMIN HCL 118 115 22 8
LOSARTAN POTASSIUM 107 89 23 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 104 97 24 25
HUMALOG 101 101 25 127
METOPROLOL TARTRATE 100 97 26 13
PREDNISONE 94 77 27 33
ATORVASTATIN CALCIUM 91 88 28 15
TRIAMTERENE-HCTZ 85 80 29 51
CRESTOR 85 81 29 34
MELOXICAM 79 79 31 23
CARVEDILOL 77 72 32 27
TERAZOSIN HCL 66 66 33 112
NOVOLOG 66 51 33 82
DIGOXIN 66 66 33 32
TRAMADOL HCL 65 60 36 18
NAMENDA 63 63 37 31
RISPERIDONE 61 61 38 65
FINASTERIDE 59 59 39 90
MIRTAZAPINE 57 57 40 43
ADVAIR DISKUS 57 44 40 60
ZOLPIDEM TARTRATE 56 56 42 20
CLOPIDOGREL 55 55 43 44
LOSARTAN-HYDROCHLOROTHIAZIDE 52 52 44 46
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 51 44 76
DETROL LA 51 51 46 136
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 13, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.